PRISM researchers based at RAND Europe have analysed the economic impact of the NIHR's Health Technology Assessment (HTA) programme, which funds research on the effectiveness, costs and impacts of healthcare technologies in the NHS.
The study looks at a sample of 10 HTA-funded projects which had showed that a new treatment, if introduced in the NHS, could offer benefits either through cost savings or improved health outcomes. It also looks at the extent to which the 10 projects impacted policy and practice.
The UK National Institute for Health Research (NIHR)‘s Health Technology Assessment (HTA) programme, established in 1993, is the largest research programme dedicated to the NHS. The underlying principle of the HTA programme is that should not only use the most rigorous techniques, but should also be needs-led, with a clear benefit to patients and practitioners.